The European Searchable Tumour Cell and Databank, ESTDAB, as a tool for research in cancer immunology by Pawelec G, Wedel L, Badalian E, Knights A, Stevanovic S, Schadendorf D, Müller L

Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma by Hemstock, M, Kupas, K, Roskell, N, Kotapati, S, Gooden, K, Middleton, MR, Schadendorf, D

New TRP-2-derived T helper epitopes identified in HLA-DRB1*0301 transgenic mice elicit spontaneous T cell responses in HLA-DRB1*03 and HLA-DRB1*04 melanoma patients by Schadendorf D, Kropshofer H, Mueller-Berghaus J, Nguyen XD, Daniel N, Thomas D, Osen W, Song M, Paschen A

Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. by Helfrich, I, Scheffrahn, I, Bartling, S, Weis, J, von Felbert, V, Middleton, M, Kato, M, Ergün, S, Augustin, H, Schadendorf, D

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study. by Robert, C, Dummer, R, Gutzmer, R, Lorigan, P, Kim, K, Nyakas, M, Arance, A, Liszkay, G, Schadendorf, D, Cantarini, M, Spencer, S, Middleton, MR

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: A phase 2 double-blind randomised study by Robert, C, Dummer, R, Gutzmer, R, Lorigan, P, Kim, K, Nyakas, M, Arance, A, Liszkay, G, Schadendorf, D, Cantarini, M, Spencer, S, Middleton, MR

Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine. by Dangoor, A, Lorigan, P, Keilholz, U, Schadendorf, D, Harris, A, Ottensmeier, C, Smyth, J, Hoffmann, K, Anderson, R, Cripps, M, Schneider, J, Hawkins, R

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF Melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial by Urbonas, V, Schadendorf, D, Zimmer, L, Danson, S, Marshall, E, Corrie, P, Wheater, M, Plummer, E, Mauch, C, Scudder, C, Goff, M, Love, S, Mohammed, S, Middleton, M

Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes by Ebstein, F, Textoris-Taube, K, Keller, C, Golnik, R, Vigneron, N, Van den Eynde, B, Schuler-Thurner, B, Schadendorf, D, Lorenz, F, Uckert, W, Urban, S, Lehmann, A, Albrecht-Koepke, N, Janek, K, Henklein, P, Niewienda, A, Kloetzel, P, Mishto, M

Improved survival with MEK inhibition in BRAF-mutated melanoma. by Flaherty, K, Robert, C, Hersey, P, Nathan, P, Garbe, C, Milhem, M, Demidov, L, Hassel, J, Rutkowski, P, Mohr, P, Dummer, R, Trefzer, U, Larkin, J, Utikal, J, Dreno, B, Nyakas, M, Middleton, M, Becker, J, Casey, M, Sherman, L, Wu, F, Ouellet, D, Martin, A, Patel, K, Schadendorf, D